Inhibition of epstein-barr virus replication by a novel L-nucleoside, 2′-fluoro-5-methyl-βL-arabinofuranosyluracil

Biochemical Pharmacology

Volumn 51, Issue 7, 1996, Pages 941-947

  Yao, Gang Qing ^a   Liu, Shwu Huey ^a   Chou, Edgar ^a   Kukhanova, Marina ^a   Chu, Chung K ^b   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Dna incorporation; L FMAU; EBV; L nucleoside; Metabolism

Indexed keywords

2' FLUORO 5 METHYL BETA DEXTRO ARABINOFURANOSYLURACIL; 2' FLUORO 5 METHYL BETA LEVO ARABINOFURANOSYLURACIL; 2' FLUORO 5 METHYL BETA LEVO ARABINOFURANOSYLURACIL DIPHOSPHATE; 2' FLUORO 5 METHYL BETA LEVO ARABINOFURANOSYLURACIL MONOPHOSPHATE; 2' FLUORO 5 METHYL BETA LEVO ARABINOFURANOSYLURACIL TRIPHOSPHATE; ACICLOVIR; CELL DNA; DNA DIRECTED DNA POLYMERASE ALPHA; DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE GAMMA; DNA POLYMERASE; GANCICLOVIR; NUCLEOSIDE DERIVATIVE; RADIOISOTOPE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; ENZYME SUBSTRATE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ARABINOFURANOSYLURACIL; AUTORADIOGRAPHY; BASE SEQUENCE; CELLS, CULTURED; DNA; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; VIRUS REPLICATION;

EID: 0029940584     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00049-4     Document Type: Article

References (25)

1. Kieff E and Liebowitz D, Epstein-Barr virus and its replication. In: Fundamental Virology (Eds. Fields BN, Chanock RM, Hirsch MS, Melnick JL, Monath TP and Roizman B), 2nd Edn, pp. 897-928. Raven Press, New York, 1991.
2. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P and Santesson L, EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056-1058, 1970.
3. Ambinder RF and Mann RB, Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 145: 239-252, 1994.
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS, Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869, 1994.
5. Colby BM, Shaw JE, Elion GB and Pagano JS, Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol 34: 560-568, 1980.
6. Lin JC, Smith MC and Pagano JS, Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother 27: 971-973, 1985.
7. Cheng YC, Huang ES, Lin JC, Mar EC, Pagano JS, Dutschman GE and Grill SP, Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci USA 80: 2767-2770, 1983.
8. Straus SE, Acyclovir in Epstein-Barr virus infections. In: Acyclovir Therapy for Herpesvirus Infections (Ed. Baker DA), pp. 269-276. Marcel Dekker, New York, 1991.
9. Macilwain C, NIH, FDA seek lessons from hepatitis B drug trial deaths. Nature 364: 275, 1993.
10. Masur H, Lane HC, Palestine A, Smith PD, Manischewitz J, Stevens G, Fujikawa L, Macher AM, Nussenblatt R, Baird B, Megill M, Wittek A, Quinnan GV, Parrillo JE, Rook AH, Eron LJ, Poretz DM, Goldenberg RI, Fauci AS and Gelmann EP, Effect of 9-1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Intern Med 104: 41-44, 1986.
11. Beach JW, Jeong LS, Alves AJ, Pohl D, Kim HO, Chang CN, Doong SL, Schinazi RF, Cheng YC and Chu CK, Synthesis of enantiomerically pure (2′R,5′S)-(-)-1-[2-(hydroxymethyl)oxathioglan-5-yl]cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J Org Chem 57: 2217-2219, 1992.
12. Chang CN, Doong SL, Zhou JH, Beach JW, Jeong LS, Chu CK, Tsai CH and Cheng YC, Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem 267: 13938-13942, 1992.
13. Lin TS, Luo MZ, Liu MC, Pai SB, Dutschman GE and Cheng YC, Synthesis and biological evaluation of 2′,3′-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J Med Chem 37: 798-803, 1994.
14. Gosselin G, Schinazi RF, Sommadossi JP, Mathé C, Bergogne MC, Aubertin AM, Kim A and Imbach JL, Anti-human immunodeficiency virus activities of the β-L-enantiomer of 2′,3′-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob Agents Chemother 38: 1292-1297, 1994.
15. Chu CK, Ma T, Shanmuganathan K, Wang C, Xiang Y, Pai SB, Yao GQ, Sommadossi JP and Cheng YC, Use of 2′-fluoro5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob Agents Chemother 39: 979-981, 1995.
16. Yao GQ, Tsai CH and Cheng YC, Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture. Virus Genes 9: 247-255, 1995.
17. Yao GQ, Grill S, Egan W and Cheng YC, Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification. Antimicrob Agents Chemother 37: 1420-1425, 1993.
18. Bresser J, Doering J and Gillespie D, Quick-blot: Selective mRNA or DNA immobilization from whole cells. DNA 2: 243-254, 1983.
19. Doong SL, Tsai CH, Schinazi RF, Liotta DC and Cheng YC, Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 88: 8495-8499, 1991.
20. Cheng YC, Grill SP, Dutschman GE, Nakayama K and Bastow KF, Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J Biol Chem 258: 12460-12464, 1983.
21. Chang CN, Skalski V, Zhou JH and Cheng YC, Biochemical pharmacology of (+)-and (-)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J Biol Chem 267: 22414-22420, 1992.
22. Kukhanova M, Liu SH, Mozzherm D, Lin TS, Chu CK and Cheng YC, L-and D-Enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrates for human DNA polymerases: Implications for the mechanism of toxicity. J Biol Chem 270: 23055-23059, 1995.
23. Chiou JF, Li JKK and Cheng YC, Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbel ester-treated Epstein-Barr virus-carrying cells. Proc Natl Acad Sci USA 82: 5728-5731, 1985.
24. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
25. Parker WB and Cheng YC, Mitochondrial toxicity of antiviral nucleoside analogs. J NIH Res 6: 57-61, 1994.